Pharmaceutical Industry

Page 10 of 100

Martin Shkreli holds his head, as if he knows how much of a headache it's going to be to convince the Supreme Court to overturn his case
Politics

Martin Shkreli gets snubbed by the Supreme Court and must return millions he reaped from jacking up the price of a lifesaving drug

By Lindsay Whitehurst and The Associated Press
October 7, 2024
Google DeepMind director of strategic initiatives, Terra Terwilliger, speaking onstage at Fortune's COO Summit.
Tech

Google DeepMind exec says AI will increase efficiency so much it’s expected to handle 50% of info requests in its legal department

By
October 7, 2024
Albert Bourla puts his palm flat on tup of his other hand, rolled up in a fist, as he sits and listens to a question onstage at a conference.
Finance

Pfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs

By
October 7, 2024
balding head
Health

Hair loss drug probed in Europe over link to suicidal thoughts

By Ashleigh Furlong and Bloomberg
October 4, 2024
woman sitting in the dark looking at a light-therapy box
Mind

Bright light therapy used for Seasonal Affective Disorder can help treat other depressions too

By
October 2, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company's headquarters in Bagsvaerd, Denmark, on Monday, June 12, 2023.
Health

Novo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders

By
September 24, 2024
Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
Finance

Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’

By Sara Sjolin, Sanne Wass, Oliver Crook and Bloomberg
September 23, 2024
COVID-19 symptoms can be mild, severe, or nonexistent, according to the Centers for Disease Control and Prevention—and can appear as late as two weeks after you’ve been exposed to the virus.
Health

Could it be COVID? Here are the symptoms to watch out for in 2024

By
September 21, 2024
Mark Cuban says he’s not going through a midlife crisis but would buy X and Fox News if he could
Leadership

Mark Cuban says he’s not going through a midlife crisis but would buy X and Fox News if he could

By
September 16, 2024
Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’
Newsletters

Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’

By
September 10, 2024
Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it
Commentary

Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it

By
September 9, 2024
The Fortune 500 is built on more than money. It’s built on human, social, and natural capital, too
Leadership

The Fortune 500 is built on more than money. It’s built on human, social, and natural capital, too

By Andre Hoffmann and Peter Vanham
September 6, 2024
Half of Denmark’s GDP growth in 2024 will be thanks to Novo Nordisk, analysts predict
Tech

Half of Denmark’s GDP growth in 2024 will be thanks to Novo Nordisk, analysts predict

By Sanne Wass and Bloomberg
September 3, 2024
Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.
Health

New COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge

By
August 29, 2024
Big Tech wants to keep stealing patents—so it’s going to war with Big Pharma
Commentary

Big Tech wants to keep stealing patents—so it’s going to war with Big Pharma

By Andrei Iancu and David J. Kappos
August 28, 2024

Most Popular